Boston Scientific Corp (BSX)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 2,282,000 | 1,985,000 | 1,141,000 | 1,076,000 | -138,000 |
| Revenue | US$ in thousands | 16,747,000 | 14,240,000 | 12,682,000 | 11,888,000 | 9,913,000 |
| Pretax margin | 13.63% | 13.94% | 9.00% | 9.05% | -1.39% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $2,282,000K ÷ $16,747,000K
= 13.63%
The pretax margin of Boston Scientific Corp has shown significant improvement over the past few years. Starting at a negative level of -1.39% in December 31, 2020, the company managed to turn around its profitability and achieve a positive pretax margin of 13.63% by December 31, 2024. This upward trend indicates that Boston Scientific Corp has been effectively managing its expenses and generating higher revenues relative to its operating costs. Overall, the company has demonstrated a strong ability to increase its profitability before accounting for taxes, which is a positive indicator of its financial performance.
Peer comparison
Dec 31, 2024